STAT5B and breast cancer: Specifically, METTL3 association with the CCND1 (cyclin D1) promoter region was reduced with STAT5B knockdown, but not STAT5A, which impaired cell cycle progression in hormone receptor-positive MCF7 breast cancer cells [60].